{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:26:20Z","timestamp":1707524780809},"reference-count":47,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,10,18]]},"DOI":"10.7759\/cureus.30425","type":"journal-article","created":{"date-parts":[[2022,10,18]],"date-time":"2022-10-18T13:57:17Z","timestamp":1666101437000},"source":"Crossref","is-referenced-by-count":4,"title":["Management of Anosmia in COVID-19: A Comprehensive Review"],"prefix":"10.7759","author":[{"given":"Khushi","family":"Khurana","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chandra Veer","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2020.8808","article-title":"Anosmia and ageusia associated with coronavirus infection (COVID-19) - what is known?","volume":"20","author":"Tanasa IA","year":"2020","unstructured":"Tanasa IA, Manciuc C, Carauleanu A, Navolan DB, Bohiltea RE, Nemescu D. Anosmia and ageusia associated with coronavirus infection (COVID-19) - what is known?. Exp Ther Med. 2020, 20:2344-7. 10.3892\/etm.2020.8808","journal-title":"Exp Ther Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmii.2020.08.010","article-title":"Olfactory disorder in patients infected with SARS-CoV-2","volume":"54","author":"Yen YF","year":"2021","unstructured":"Yen YF, Lai HH, Chan SY, et al.. Olfactory disorder in patients infected with SARS-CoV-2. J Microbiol Immunol Infect. 2021, 54:992-6. 10.1016\/j.jmii.2020.08.010","journal-title":"J Microbiol Immunol Infect"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1101\/2020.02.22.20026500","article-title":"Neurological manifestations of hospitalized patients with COVID-19 in Wuhan, China: a retrospective case series study","author":"Mao L","year":"2020","unstructured":"Mao L, Wang M, Chen S, et al.. Neurological manifestations of hospitalized patients with COVID-19 in Wuhan, China: a retrospective case series study. MedRxiv. 2020, 10.1101\/2020.02.22.20026500","journal-title":"MedRxiv"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1177\/0194599820926473","article-title":"The prevalence of olfactory and gustatory dysfunction in COVID-19 patients: A systematic review and meta-analysis","volume":"163","author":"Tong JY","year":"2020","unstructured":"Tong JY, Wong A, Zhu D, Fastenberg JH, Tham T. The prevalence of olfactory and gustatory dysfunction in COVID-19 patients: A systematic review and meta-analysis. Otolaryngol Head Neck Surg. 2020, 163:3-11. 10.1177\/0194599820926473","journal-title":"Otolaryngol Head Neck Surg"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(20)30079-5","article-title":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study","volume":"8","author":"Yang X","year":"2020","unstructured":"Yang X, Yu Y, Xu J, et al.. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020, 8:475-81. 10.1016\/S2213-2600(20)30079-5","journal-title":"Lancet Respir Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang C","year":"2020","unstructured":"Huang C, Wang Y, Li X, et al.. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020, 395:497-506. 10.1016\/S0140-6736(20)30183-5","journal-title":"Lancet"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1177\/1756286420917830","article-title":"Potential neurological symptoms of COVID-19","volume":"13","author":"Wang HY","year":"2020","unstructured":"Wang HY, Li XL, Yan ZR, Sun XP, Han J, Zhang BW. Potential neurological symptoms of COVID-19. Ther Adv Neurol Disord. 2020, 13:1756286420917830. 10.1177\/1756286420917830","journal-title":"Ther Adv Neurol Disord"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1177\/0194599820922992","article-title":"COVID-19 anosmia reporting tool: Initial findings","volume":"163","author":"Kaye R","year":"2020","unstructured":"Kaye R, Chang CW, Kazahaya K, Brereton J, Denneny JC 3rd. COVID-19 anosmia reporting tool: Initial findings. Otolaryngol Head Neck Surg. 2020, 163:132-4. 10.1177\/0194599820922992","journal-title":"Otolaryngol Head Neck Surg"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1002\/alr.22593","article-title":"Potential pathogenesis of ageusia and anosmia in COVID-19 patients","volume":"10","author":"Vaira LA","year":"2020","unstructured":"Vaira LA, Salzano G, Fois AG, Piombino P, De Riu G. Potential pathogenesis of ageusia and anosmia in COVID-19 patients. Int Forum Allergy Rhinol. 2020, 10:1103-4. 10.1002\/alr.22593","journal-title":"Int Forum Allergy Rhinol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/jnc.15197","article-title":"Viral infection and smell loss: The case of COVID-19","volume":"157","author":"Glezer I","year":"2021","unstructured":"Glezer I, Bruni-Cardoso A, Schechtman D, Malnic B. Viral infection and smell loss: The case of COVID-19. J Neurochem. 2021, 157:930-43. 10.1111\/jnc.15197","journal-title":"J Neurochem"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1093\/chemse\/bjaa040","article-title":"Anosmia in COVID-19: Mechanisms and significance","author":"Han AY","year":"2020","unstructured":"Han AY, Mukdad L, Long JL, Lopez IA. Anosmia in COVID-19: Mechanisms and significance. Chem Senses. 2020, 10.1093\/chemse\/bjaa040","journal-title":"Chem Senses"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abc5801","article-title":"Non-neuronal expression of SARS-CoV-2 entry genes in the olfactory system suggests mechanisms underlying COVID-19-associated anosmia","volume":"6","author":"Brann DH","year":"2020","unstructured":"Brann DH, Tsukahara T, Weinreb C, et al.. Non-neuronal expression of SARS-CoV-2 entry genes in the olfactory system suggests mechanisms underlying COVID-19-associated anosmia. Sci Adv. 2020, 6:10.1126\/sciadv.abc5801","journal-title":"Sci Adv"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2021.174582","article-title":"Potential pharmacologic treatments for COVID-19 smell and taste loss: A comprehensive review","volume":"912","author":"Khani E","year":"2021","unstructured":"Khani E, Khiali S, Beheshtirouy S, Entezari-Maleki T. Potential pharmacologic treatments for COVID-19 smell and taste loss: A comprehensive review. Eur J Pharmacol. 2021, 912:174582. 10.1016\/j.ejphar.2021.174582","journal-title":"Eur J Pharmacol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjms.2020.06.012","article-title":"Association of COVID-19 with anosmia and hypogeusia","volume":"360","author":"Nasir S","year":"2020","unstructured":"Nasir S, Iftikhar PM. Association of COVID-19 with anosmia and hypogeusia. Am J Med Sci. 2020, 360:414. 10.1016\/j.amjms.2020.06.012","journal-title":"Am J Med Sci"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1038\/s41593-020-00758-5","article-title":"Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19","volume":"24","author":"Meinhardt J","year":"2021","unstructured":"Meinhardt J, Radke J, Dittmayer C, et al.. Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19. Nat Neurosci. 2021, 24:168-75. 10.1038\/s41593-020-00758-5","journal-title":"Nat Neurosci"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1002\/lary.28692","article-title":"Anosmia and ageusia: Common findings in COVID-19 patients","volume":"130","author":"Vaira LA","year":"2020","unstructured":"Vaira LA, Salzano G, Deiana G, De Riu G. Anosmia and ageusia: Common findings in COVID-19 patients. Laryngoscope. 2020, 130:1787. 10.1002\/lary.28692","journal-title":"Laryngoscope"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3390\/v13020262","article-title":"Sialic acid receptors: The key to solving the enigma of zoonotic virus spillover","volume":"13","author":"Kuchipudi SV","year":"2021","unstructured":"Kuchipudi SV, Nelli RK, Gontu A, Satyakumar R, Surendran Nair M, Subbiah M. Sialic acid receptors: The key to solving the enigma of zoonotic virus spillover. Viruses. 2021, 13:10.3390\/v13020262","journal-title":"Viruses"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1021\/acschemneuro.0c00249","article-title":"Proinflammatory cytokines in the olfactory mucosa result in COVID-19 induced anosmia","volume":"11","author":"Torabi A","year":"2020","unstructured":"Torabi A, Mohammadbagheri E, Akbari Dilmaghani N, et al.. Proinflammatory cytokines in the olfactory mucosa result in COVID-19 induced anosmia. ACS Chem Neurosci. 2020, 11:1909-13. 10.1021\/acschemneuro.0c00249","journal-title":"ACS Chem Neurosci"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjoto.2020.102725","article-title":"Early recovery patterns of olfactory disorders in COVID-19 patients; a clinical cohort study","volume":"41","author":"Amer MA","year":"2020","unstructured":"Amer MA, Elsherif HS, Abdel-Hamid AS, Elzayat S. Early recovery patterns of olfactory disorders in COVID-19 patients; a clinical cohort study. Am J Otolaryngol. 2020, 41:102725. 10.1016\/j.amjoto.2020.102725","journal-title":"Am J Otolaryngol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2020.00229","article-title":"SARS-CoV-2 dissemination through peripheral nerves explains multiple organ injury","volume":"14","author":"Fenrich M","year":"2020","unstructured":"Fenrich M, Mrdenovic S, Balog M, et al.. SARS-CoV-2 dissemination through peripheral nerves explains multiple organ injury. Front Cell Neurosci. 2020, 14:229. 10.3389\/fncel.2020.00229","journal-title":"Front Cell Neurosci"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1177\/0194599820965920","article-title":"Olfactory cleft measurements and COVID-19-related anosmia","volume":"164","author":"Altundag A","year":"2021","unstructured":"Altundag A, Y\u0131ld\u0131r\u0131m D, Tekcan Sanli DE, et al.. Olfactory cleft measurements and COVID-19-related anosmia. Otolaryngol Head Neck Surg. 2021, 164:1337-44. 10.1177\/0194599820965920","journal-title":"Otolaryngol Head Neck Surg"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2020.2125","article-title":"Magnetic resonance imaging alteration of the brain in a patient with coronavirus disease 2019 (COVID-19) and anosmia","volume":"77","author":"Politi LS","year":"2020","unstructured":"Politi LS, Salsano E, Grimaldi M. Magnetic resonance imaging alteration of the brain in a patient with coronavirus disease 2019 (COVID-19) and anosmia. JAMA Neurol. 2020, 77:1028-9. 10.1001\/jamaneurol.2020.2125","journal-title":"JAMA Neurol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016%2Fj.acra.2020.10.006","article-title":"Olfactory bulb MRI and paranasal sinus CT findings in persistent COVID-19 anosmia","volume":"28","author":"Kandemirli G","year":"2021","unstructured":"Kandemirli G, Altundag A, Yildirim D, Sanli T, Saatci O. Olfactory bulb MRI and paranasal sinus CT findings in persistent COVID-19 anosmia . Academic radiology. 2021, 28:28-35. 10.1016%2Fj.acra.2020.10.006","journal-title":"Academic radiology"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abf8396","article-title":"COVID-19-related anosmia is associated with viral persistence and inflammation in human olfactory epithelium and brain infection in hamsters","volume":"13","author":"de Melo GD","year":"2021","unstructured":"de Melo GD, Lazarini F, Levallois S, et al.. COVID-19-related anosmia is associated with viral persistence and inflammation in human olfactory epithelium and brain infection in hamsters. Sci Transl Med. 2021, 13:10.1126\/scitranslmed.abf8396","journal-title":"Sci Transl Med"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2020.07.005","article-title":"Self-reported loss of smell without nasal obstruction to identify COVID-19. The multicenter Coranosmia cohort study","volume":"81","author":"Salmon Ceron D","year":"2020","unstructured":"Salmon Ceron D, Bartier S, Hautefort C, et al.. Self-reported loss of smell without nasal obstruction to identify COVID-19. The multicenter Coranosmia cohort study. J Infect. 2020, 81:614-20. 10.1016\/j.jinf.2020.07.005","journal-title":"J Infect"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-021-01367-8","article-title":"Headache, anosmia, ageusia and other neurological symptoms in COVID-19: a cross-sectional study","volume":"23","author":"Sampaio Rocha-Filho PA","year":"2022","unstructured":"Sampaio Rocha-Filho PA, Albuquerque PM, Carvalho LC, Dandara Pereira Gama M, Magalh\u00e3es JE. Headache, anosmia, ageusia and other neurological symptoms in COVID-19: a cross-sectional study. J Headache Pain. 2022, 23:2. 10.1186\/s10194-021-01367-8","journal-title":"J Headache Pain"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1007\/s00405-020-05965-1","article-title":"Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study","volume":"277","author":"Lechien JR","year":"2020","unstructured":"Lechien JR, Chiesa-Estomba CM, De Siati DR, et al.. Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study. Eur Arch Otorhinolaryngol. 2020, 277:2251-61. 10.1007\/s00405-020-05965-1","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.8391","article-title":"Olfactory dysfunction in COVID-19: Diagnosis and management","volume":"323","author":"Whitcroft KL","year":"2020","unstructured":"Whitcroft KL, Hummel T. Olfactory dysfunction in COVID-19: Diagnosis and management. JAMA. 2020, 323:2512-4. 10.1001\/jama.2020.8391","journal-title":"JAMA"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoto.2019.1728","article-title":"Clinical diagnosis and current management strategies for olfactory dysfunction: A review","volume":"145","author":"Whitcroft KL","year":"2019","unstructured":"Whitcroft KL, Hummel T. Clinical diagnosis and current management strategies for olfactory dysfunction: A review. JAMA Otolaryngol Head Neck Surg. 2019, 145:846-53. 10.1001\/jamaoto.2019.1728","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1021\/acschemneuro.1c00477","article-title":"Mechanism of anosmia caused by symptoms of COVID-19 and emerging treatments","volume":"12","author":"Najafloo R","year":"2021","unstructured":"Najafloo R, Majidi J, Asghari A, et al.. Mechanism of anosmia caused by symptoms of COVID-19 and emerging treatments. ACS Chem Neurosci. 2021, 12:3795-805. 10.1021\/acschemneuro.1c00477","journal-title":"ACS Chem Neurosci"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1007\/s00405-020-06520-8","article-title":"Efficacy and safety of oral corticosteroids and olfactory training in the management of COVID-19-related loss of smell","volume":"278","author":"Le Bon SD","year":"2021","unstructured":"Le Bon SD, Konopnicki D, Pisarski N, Prunier L, Lechien JR, Horoi M. Efficacy and safety of oral corticosteroids and olfactory training in the management of COVID-19-related loss of smell. Eur Arch Otorhinolaryngol. 2021, 278:3113-7. 10.1007\/s00405-020-06520-8","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjoto.2020.102884","article-title":"Corticosteroid nasal spray for recovery of smell sensation in COVID-19 patients: A randomized controlled trial","volume":"42","author":"Abdelalim AA","year":"2021","unstructured":"Abdelalim AA, Mohamady AA, Elsayed RA, Elawady MA, Ghallab AF. Corticosteroid nasal spray for recovery of smell sensation in COVID-19 patients: A randomized controlled trial. Am J Otolaryngol. 2021, 42:102884. 10.1016\/j.amjoto.2020.102884","journal-title":"Am J Otolaryngol"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.5152\/B-ENT.2020.20127","article-title":"COVID-19 and olfactory dysfunction - an ENT perspective to the current COVID-19 pandemic","volume":"16","author":"Vroegop AV","year":"2020","unstructured":"Vroegop AV, Eeckels AS, Rompaey VV, et al.. COVID-19 and olfactory dysfunction - an ENT perspective to the current COVID-19 pandemic. B-ENT. 2020, 16:81-5. 10.5152\/B-ENT.2020.20127","journal-title":"B-ENT"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjoto.2021.103033","article-title":"Effect of nasal corticosteroid in the treatment of anosmia due to COVID-19: A randomised double-blind placebo-controlled study","volume":"42","author":"Rashid RA","year":"2021","unstructured":"Rashid RA, Zgair A, Al-Ani RM. Effect of nasal corticosteroid in the treatment of anosmia due to COVID-19: A randomised double-blind placebo-controlled study. Am J Otolaryngol. 2021, 42:103033. 10.1016\/j.amjoto.2021.103033","journal-title":"Am J Otolaryngol"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjoto.2020.102892","article-title":"The outcome of fluticasone nasal spray on anosmia and triamcinolone oral paste in dysgeusia in COVID-19 patients","volume":"42","author":"Singh CV","year":"2021","unstructured":"Singh CV, Jain S, Parveen S. The outcome of fluticasone nasal spray on anosmia and triamcinolone oral paste in dysgeusia in COVID-19 patients. Am J Otolaryngol. 2021, 42:102892. 10.1016\/j.amjoto.2020.102892","journal-title":"Am J Otolaryngol"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.21203\/rs.3.rs-76002\/v2","article-title":"Treatment of anosmia and ageusia in COVID-19 patients by using Coffee","author":"Hosseini A","year":"2020","unstructured":"Hosseini A, Mirmahdi E, Moghadam MA. Treatment of anosmia and ageusia in COVID-19 patients by using Coffee. Review. 2020, 10.21203\/rs.3.rs-76002\/v2","journal-title":"Review"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1051\/irm\/2020003","article-title":"A new strategy for treatment of anosmia and ageusia in COVID-19 patients","volume":"1","author":"Hosseini A","year":"2020","unstructured":"Hosseini A, Mirmahdi E, Moghaddam MA. A new strategy for treatment of anosmia and ageusia in COVID-19 patients. Integr Respir Med. 2020, 1:2. 10.1051\/irm\/2020003","journal-title":"Integr Respir Med"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2021.120600","article-title":"Insulin fast-dissolving film for intranasal delivery via olfactory region, a promising approach for the treatment of anosmia in COVID-19 patients: Design, in-vitro characterization and clinical evaluation","volume":"601","author":"Mohamad SA","year":"2021","unstructured":"Mohamad SA, Badawi AM, Mansour HF. Insulin fast-dissolving film for intranasal delivery via olfactory region, a promising approach for the treatment of anosmia in COVID-19 patients: Design, in-vitro characterization and clinical evaluation. Int J Pharm. 2021, 601:120600. 10.1016\/j.ijpharm.2021.120600","journal-title":"Int J Pharm"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1097\/00005537-200402000-00018","article-title":"Pathology of the olfactory mucosa: implications for the treatment of olfactory dysfunction","volume":"114","author":"Kern RC","year":"2004","unstructured":"Kern RC, Conley DB, Haines GK, Robinson AM. Pathology of the olfactory mucosa: implications for the treatment of olfactory dysfunction. Laryngoscope. 2004, 114:279-85. 10.1097\/00005537-200402000-00018","journal-title":"Laryngoscope"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/5892047","article-title":"Oral corticosteroid relieves post-COVID-19 anosmia in a 35-year-old patient","volume":"2020","author":"Touisserkani SK","year":"2020","unstructured":"Touisserkani SK, Ayatollahi A. Oral corticosteroid relieves post-COVID-19 anosmia in a 35-year-old patient. Case Rep Otolaryngol. 2020, 2020:5892047. 10.1155\/2020\/5892047","journal-title":"Case Rep Otolaryngol"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.2500\/ajra.2016.30.4313","article-title":"Protective effects of melatonin and selenium against apoptosis of olfactory sensory neurons: A rat model study","volume":"30","author":"Koc S","year":"2016","unstructured":"Koc S, Cayli S, Aksakal C, Ocakli S, Soyalic H, Somuk BT, Y\u00fcce S. Protective effects of melatonin and selenium against apoptosis of olfactory sensory neurons: A rat model study. Am J Rhinol Allergy. 2016, 30:62-6. 10.2500\/ajra.2016.30.4313","journal-title":"Am J Rhinol Allergy"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1007\/s10571-020-00938-8","article-title":"Coronavirus disease 2019 (COVID-19) and its neuroinvasive capacity: Is it time for melatonin?","volume":"42","author":"Romero A","year":"2022","unstructured":"Romero A, Ramos E, L\u00f3pez-Mu\u00f1oz F, Gil-Mart\u00edn E, Escames G, Reiter RJ. Coronavirus disease 2019 (COVID-19) and its neuroinvasive capacity: Is it time for melatonin?. Cell Mol Neurobiol. 2022, 42:489-500. 10.1007\/s10571-020-00938-8","journal-title":"Cell Mol Neurobiol"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1177\/1073858420956905","article-title":"Anosmia in COVID-19: Underlying mechanisms and assessment of an olfactory route to brain infection","volume":"27","author":"Butowt R","year":"2021","unstructured":"Butowt R, von Bartheld CS. Anosmia in COVID-19: Underlying mechanisms and assessment of an olfactory route to brain infection. Neuroscientist. 2021, 27:582-603. 10.1177\/1073858420956905","journal-title":"Neuroscientist"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1007\/s00405-020-06575-7","article-title":"Impact of the smell loss on the quality of life and adopted coping strategies in COVID-19 patients","volume":"278","author":"Elkholi SM","year":"2021","unstructured":"Elkholi SM, Abdelwahab MK, Abdelhafeez M. Impact of the smell loss on the quality of life and adopted coping strategies in COVID-19 patients. Eur Arch Otorhinolaryngol. 2021, 278:3307-14. 10.1007\/s00405-020-06575-7","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1016\/j.jadr.2021.100156","article-title":"Association of COVID19-induced anosmia and ageusia with depression and suicidal ideation","volume":"5","author":"Yom-Tov E","year":"2021","unstructured":"Yom-Tov E, Lekkas D, Jacobson NC. Association of COVID19-induced anosmia and ageusia with depression and suicidal ideation. J Affect Disord Rep. 2021, 5:100156. 10.1016\/j.jadr.2021.100156","journal-title":"J Affect Disord Rep"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1007\/s00405-020-06069-6","article-title":"The role of self-reported smell and taste disorders in suspected COVID\u201119","volume":"277","author":"Printza A","year":"2020","unstructured":"Printza A, Constantinidis J. The role of self-reported smell and taste disorders in suspected COVID\u201119. Eur Arch Otorhinolaryngol. 2020, 277:2625-30. 10.1007\/s00405-020-06069-6","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1016\/j.jiph.2020.09.008","article-title":"Association of corticosteroids use and outcomes in COVID-19 patients: A systematic review and meta-analysis","volume":"13","author":"Tlayjeh H","year":"2020","unstructured":"Tlayjeh H, Mhish OH, Enani MA, et al.. Association of corticosteroids use and outcomes in COVID-19 patients: A systematic review and meta-analysis. J Infect Public Health. 2020, 13:1652-63. 10.1016\/j.jiph.2020.09.008","journal-title":"J Infect Public Health"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/116993-management-of-anosmia-in-covid-19-a-comprehensive-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:51:44Z","timestamp":1707508304000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/116993-management-of-anosmia-in-covid-19-a-comprehensive-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,18]]},"references-count":47,"URL":"https:\/\/doi.org\/10.7759\/cureus.30425","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10,18]]}}}